Presentation is loading. Please wait.

Presentation is loading. Please wait.

Treatment of psoriasis vulgaris using low-dose naltrexone

Published byMargaretMargaret Hall Modified over 5 years ago

Similar presentations

Presentation on theme: "Treatment of psoriasis vulgaris using low-dose naltrexone"— Presentation transcript:

1 Treatment of psoriasis vulgaris using low-dose naltrexone
Alanna C. Bridgman, MSc, Mark G. Kirchhof, MD, PhD, FRCPC  JAAD Case Reports  Volume 4, Issue 8, Pages (September 2018) DOI: /j.jdcr Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 Clinical response of psoriasis to low-dose naltrexone. Psoriasis disease status as measured by BSA and PASI in relation to treatments over 27-month timeline. JAAD Case Reports 2018 4, DOI: ( /j.jdcr ) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions

Download ppt "Treatment of psoriasis vulgaris using low-dose naltrexone"

Similar presentations

Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP)  Jeff Donovan, MD, PhD, FRCPC  JAAD.

Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP)  Jeff Donovan, MD, PhD, FRCPC  JAAD.
Jeff Donovan, MD, PhD, FRCPC  JAAD Case Reports 

Jeff Donovan, MD, PhD, FRCPC  JAAD Case Reports 
Repigmentation and new growth of hairs after anti–interleukin-17 therapy with secukinumab for psoriasis  Franco Rongioletti, MD, Cristina Mugheddu, MD,

Repigmentation and new growth of hairs after anti–interleukin-17 therapy with secukinumab for psoriasis  Franco Rongioletti, MD, Cristina Mugheddu, MD,
Marc Mrad, MD, MSc, Nakhle Ayoub, MD, Ribal Mehi, MD  JAAD Case Reports 

Marc Mrad, MD, MSc, Nakhle Ayoub, MD, Ribal Mehi, MD  JAAD Case Reports 
Sara B. Ferguson, MD, Elisa S. Gallo, MD  JAAD Case Reports 

Sara B. Ferguson, MD, Elisa S. Gallo, MD  JAAD Case Reports 
Volume 2, Issue 1, Pages 1-3 (January 2016)

Volume 2, Issue 1, Pages 1-3 (January 2016)
Alopecia after injection of ATX-101 for reduction of submental fat

Alopecia after injection of ATX-101 for reduction of submental fat
Hemorrhagic lesion on the chest wall after trauma

Hemorrhagic lesion on the chest wall after trauma
Volume 1, Issue 5, Pages (September 2015)

Volume 1, Issue 5, Pages (September 2015)
Volume 1, Issue 5, Pages (September 2015)

Volume 1, Issue 5, Pages (September 2015)
Alopecia areata after dupilumab for atopic dermatitis

Alopecia areata after dupilumab for atopic dermatitis
Volume 3, Issue 3, Pages (May 2017)

Volume 3, Issue 3, Pages (May 2017)
An enlarging, ulcerated scalp nodule

An enlarging, ulcerated scalp nodule
Conjunctivitis, mucosal erosions, and moist cutaneous plaques

Conjunctivitis, mucosal erosions, and moist cutaneous plaques
Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP)  Jeff Donovan, MD, PhD, FRCPC  JAAD.

Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP)  Jeff Donovan, MD, PhD, FRCPC  JAAD.
The role of interleukin-1β in pyoderma gangrenosum

The role of interleukin-1β in pyoderma gangrenosum
Development of bullous pemphigoid during nivolumab therapy

Development of bullous pemphigoid during nivolumab therapy
Flesh-colored papules and nodules on the face

Flesh-colored papules and nodules on the face
Volume 4, Issue 8, Pages (September 2018)

Volume 4, Issue 8, Pages (September 2018)
Is the hip prosthesis responsible for this rash?

Is the hip prosthesis responsible for this rash?

Similar presentations

Ads by Google